{"id":18987,"date":"2024-12-27T12:00:05","date_gmt":"2024-12-27T13:00:05","guid":{"rendered":"http:\/\/medexperts.pro\/?p=18987"},"modified":"2024-12-27T13:25:19","modified_gmt":"2024-12-27T13:25:19","slug":"openai-details-plans-for-becoming-a-for-profit-company","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=18987","title":{"rendered":"OpenAI Details Plans for Becoming a For-Profit Company"},"content":{"rendered":"<div><\/div>\n<p id=\"article-summary\" class=\"css-79rysd e1wiw3jv0\">OpenAI said it will be restructured as a public benefit corporation, and the nonprofit that controls the organization would receive shares in the new company.<\/p>\n<section class=\"meteredContent css-1r7ky0e\">\n<div class=\"css-s99gbd StoryBodyCompanionColumn\" data-testid=\"companionColumn-0\">\n<div class=\"css-53u6y8\">\n<p class=\"css-at9mc1 evys1bk0\">OpenAI revealed details on Friday about its plans to adopt a new corporate structure that will remove the company from control by a nonprofit that has been the focus of contention.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">OpenAI\u2019s leaders have been privately discussing a change for several months but have provided few specifics.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">In a company blog post published on Friday, OpenAI said it planned to restructure as a public benefit corporation, or P.B.C., which is a for-profit corporation designed to create public and social good. OpenAI rivals like Anthropic and <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2024\/12\/24\/technology\/elon-musk-xai-funding.html\" title>Elon Musk\u2019s xAI<\/a> use a similar structure.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">\u201cThe P.B.C. is a structure used by many others that requires the company to balance shareholder interests, stakeholder interests, and a public benefit interest in its decision making,\u201d the company said. \u201cIt will enable us to raise the necessary capital with conventional terms like our competitors.\u201d<\/p>\n<\/div>\n<\/div>\n<div data-testid=\"Dropzone-1\"><\/div>\n<div class=\"css-s99gbd StoryBodyCompanionColumn\" data-testid=\"companionColumn-1\">\n<div class=\"css-53u6y8\">\n<p class=\"css-at9mc1 evys1bk0\">A year ago, the board of the nonprofit <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2023\/11\/22\/technology\/how-sam-altman-returned-openai.html\" title>tried<\/a> to fire the company\u2019s chief executive, Sam Altman. It failed, but the incident spooked OpenAI\u2019s investors, including the tech giant Microsoft. In the months since, Mr. Altman and his colleagues have been <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2024\/12\/17\/technology\/openai-nonprofit-control.html\" title>working toward a new structure<\/a>.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">With the change in structure, Mr. Altman and his colleagues must find ways to compensate the nonprofit for its loss of control. OpenAI said the nonprofit would receive shares in the P.B.C. but added that the value it would receive was still being negotiated by independent financial advisers.<\/p>\n<div class=\"css-1336jj\">\n<div class=\"css-121kum4\">\n<div class=\"css-171d1bw\"><\/div>\n<div class=\"css-asuuk5\">\n<div class=\"css-7axq9l\" data-testid=\"optimistic-truncator-noscript\">\n<div data-testid=\"optimistic-truncator-noscript-message\" class=\"css-6yo1no\">\n<p class=\"css-3kpklk\">We are having trouble retrieving the article content.<\/p>\n<p class=\"css-3kpklk\">Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n<div class=\"css-1dv1kvn\" id=\"optimistic-truncator-a11y\">\n<hr \/>\n<p>Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0<a href=\"https:\/\/myaccount.nytimes.com\/auth\/login?response_type=cookie&amp;client_id=vi&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2024%2F12%2F27%2Ftechnology%2Fopenai-public-benefit-corporation.html&amp;asset=opttrunc\">log into<\/a>\u00a0your Times account, or\u00a0<a href=\"https:\/\/www.nytimes.com\/subscription?campaignId=89WYR&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2024%2F12%2F27%2Ftechnology%2Fopenai-public-benefit-corporation.html\">subscribe<\/a>\u00a0for all of The Times.<\/p>\n<hr \/>\n<\/div>\n<div class=\"css-1g71tqy\">\n<div data-testid=\"optimistic-truncator-message\" class=\"css-6yo1no\">\n<p class=\"css-3kpklk\">Thank you for your patience while we verify access.<\/p>\n<p class=\"css-3kpklk\">Already a subscriber?\u00a0<a data-testid=\"log-in-link\" class=\"css-z5ryv4\" href=\"https:\/\/myaccount.nytimes.com\/auth\/login?response_type=cookie&amp;client_id=vi&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2024%2F12%2F27%2Ftechnology%2Fopenai-public-benefit-corporation.html&amp;asset=opttrunc\">Log in<\/a>.<\/p>\n<p class=\"css-3kpklk\">Want all of The Times?\u00a0<a data-testid=\"subscribe-link\" class=\"css-z5ryv4\" href=\"https:\/\/www.nytimes.com\/subscription?campaignId=89WYR&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2024%2F12%2F27%2Ftechnology%2Fopenai-public-benefit-corporation.html\">Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>OpenAI said it will be restructured as a public benefit corporation, and the nonprofit that controls the organization would receive shares in the new company.OpenAI revealed details on Friday about its plans to adopt a new corporate structure that will remove the company from control by a nonprofit that has been the focus of contention.OpenAI\u2019s leaders have been privately discussing a change for several months but have provided few specifics.In a company blog post published on Friday, OpenAI said it planned to restructure as a public benefit corporation, or P.B.C., which is a for-profit corporation designed to create public and social good. OpenAI rivals like Anthropic and Elon Musk\u2019s xAI use a similar structure.\u201cThe P.B.C. is a structure used by many others that requires the company to balance shareholder interests, stakeholder interests, and a public benefit interest in its decision making,\u201d the company said. \u201cIt will enable us to raise the necessary capital with conventional terms like our competitors.\u201dA year ago, the board of the nonprofit tried to fire the company\u2019s chief executive, Sam Altman. It failed, but the incident spooked OpenAI\u2019s investors, including the tech giant Microsoft. In the months since, Mr. Altman and his colleagues have been working toward a new structure.With the change in structure, Mr. Altman and his colleagues must find ways to compensate the nonprofit for its loss of control. OpenAI said the nonprofit would receive shares in the P.B.C. but added that the value it would receive was still being negotiated by independent financial advisers.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":18989,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-18987","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/18987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18987"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/18987\/revisions"}],"predecessor-version":[{"id":18990,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/18987\/revisions\/18990"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/18989"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}